https://www.selleckchem.com/pr....oducts/Vorinostat-sa
R158P in the poroma and NOTCH2 p.G329S in the trichoblastoma. TP53 p.R158P has been determined as a pathogenic mutation in other tumors, and NOTCH2 p.G329S was a novel mutation. We identified two novel mutations that may have contributed to the pathogenesis of the secondary tumor's development. The roles of the mutations remain unclear.There is a persistent misconception that risk analysis is only suited for considering the immediate consequences of an event. Such a limitation would make risk analysis unsuitable for many challen
Like
Comment
Share
